GMRE trades 11.9% below Wall Street's consensus target of $40.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes GMRE achieves its forward estimates and maintains a stable P/E multiple of 595.7x. This scenario reflects the blended consensus of 22 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Global Medical REIT Inc. (GMRE) has a Wall Street consensus price target of $40.00, based on estimates from 22 covering analysts. With the stock currently trading at $35.74, this represents a potential upside of +11.9%. The company has a market capitalization of $94M.
Analyst price targets range from a low of $40.00 to a high of $40.00, representing a 0% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, GMRE trades at a trailing P/E of 115.3x and forward P/E of 595.7x. Analysts expect EPS to grow +106.6% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CHCTCommunity Healthcare Trust Incorporated | $498M | $17.43 | $18.50 | +6.1% | Hold | 37.1x | 16 |
NXRTNexPoint Residential Trust, Inc. | $684M | $26.97 | $27.00 | +0.1% | Hold | — | 10 |
PLYMPlymouth Industrial REIT, Inc. | $979M | $21.98 | $21.00 | -4.5% | Hold | — | 16 |
HRHealthcare Realty Trust Incorporated | $6.9B | $19.79 | $21.83 | +10.3% | Hold | — | 30 |
DOCHealthpeak Properties, Inc. | $13.6B | $19.56 | $19.71 | +0.8% | Buy | 65.5x | 41 |
MPWMedical Properties Trust, Inc. | $3.4B | $5.65 | $11.54 | +104.2% | Hold | 49.4x | 28 |
OHIOmega Healthcare Investors, Inc. | $13.3B | $44.53 | $50.43 | +13.2% | Hold | 22.4x | 28 |
SBRASabra Health Care REIT, Inc. | $4.6B | $18.12 | $21.00 | +15.9% | Hold | 26.9x | 29 |
LTCLTC Properties, Inc. | $1.9B | $36.37 | $36.00 | -1.0% | Hold | 19.4x | 22 |
CTRECareTrust REIT, Inc. | $8.8B | $37.06 | $44.25 | +19.4% | Buy | 24.8x | 19 |
Quick answers to the most common questions about buying GMRE stock.
Global Medical REIT Inc. (GMRE) has a consensus 12-month price target of $40, implying 11.9% upside from $35.74. The 22 analysts covering GMRE see moderate appreciation potential.
GMRE has a consensus rating of "Buy" based on 22 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $40 implies 11.9% upside from current levels.
At a forward P/E of 595.6667x, GMRE trades at a premium valuation. The consensus price target of $40 (11.9% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $40 for GMRE, while the most conservative target is $40. The consensus of $40 represents the median expectation. These targets typically reflect 12-month expectations.
GMRE is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month GMRE stock forecast based on 22 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $40 (bear case) to $40 (bull case). The median consensus rating is "Buy".
GMRE trades at a forward P/E ratio of 595.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 115.3x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on GMRE, with a "Buy" consensus rating and $40 price target (11.9% upside). 13 of 22 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
GMRE analyst price targets range from $40 to $40, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.